细胞死亡和癌症免疫疗法的免疫性与免疫检查点抑制剂
Elena Catanzaro1,2, Manuel Beltrán-Visiedo3, Lorenzo Galluzzi4
1Cell Death Investigation and Therapy (CDIT) Laboratory, Anatomy and Embryology Unit, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Cellular & molecular immunology
|December 9, 2024
概括
将免疫疗法与免疫检查点抑制剂 (ICI) 和免疫细胞死亡 (ICD) 诱导剂相结合,在癌症治疗方面表现有前途. 需要策略来克服挑战,并提高这些组合疗法的疗效.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 癌症研究 癌症研究
背景情况:
- 用免疫检查点抑制剂 (ICI) 进行的免疫疗法已经改变了癌症护理,但在许多患者中面临阻力.
- 组合策略对于提高ICI有效性至关重要.
- 免疫性细胞死亡 (ICD) 诱导剂正在被探索,因为它们有可能增强抗瘤适应性免疫反应.
研究的目的:
- 在癌症中审查ICD诱导剂和ICI之间的治疗相互作用.
- 确定导致临床前和临床结果之间的差异的因素.
- 提出提高组合疗法的疗效的策略.
主要方法:
- 关于ICD诱导剂和ICI的临床前和临床研究的文献综述.
- 对影响组合治疗结果的因素的分析.
- 讨论改善临床疗效的挑战和潜在解决方案.
主要成果:
- ICD诱导剂和ICI的组合可以启动瘤向的适应性免疫.
- 这些组合的临床结果并没有始终超过单一疗法.
- 在临床前和临床发现之间存在差异.
结论:
- 需要进一步的研究,以优化ICI与ICI的ICD诱导器的使用.
- 解决已确定的挑战对于最大限度地提高这些组合的临床益处至关重要.
- 开发新的策略可以改善患者对联合免疫疗法的反应.
相关概念视频
Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
Cancer Vaccines
338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338
Cytotoxic T Cells-mediated Immune Response
846
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
846
Cell-mediated Immune Responses
67.0K
Overview
67.0K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


